Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 29, 2025
authID Announces Strategic Partnership with TechDemocracy to Accelerate Passwordless Identity for Workforce & Customer Access
GlobeNewswire
·
April 29, 2025
Leading cybersecurity services firm to train its team on authID’s biometric authentication and verification platforms, aiming to accelerate the adoption of secure and privacy-preserving passwordless solutions. Denver, Colorado and Piscataway, New Jersey, …
Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
GlobeNewswire
·
April 29, 2025
WILMETTE, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced that data on the long …
BigCommerce and Feedonomics Announce Winners of APAC Region Customer and Partner Awards to Honor Exceptional Contributions and Results in Ecommerce
GlobeNewswire
·
April 29, 2025
AUSTIN, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced the winners of the 2025 BigCommerce …
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF)
GlobeNewswire
·
April 29, 2025
WATERTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 29, 2025
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2025. “In Q1, …
APR Energy Delivers 150MW Fast Power to Support Mexico’s Grid
GlobeNewswire
·
April 29, 2025
JACKSONVILLE, Fla., April 29, 2025 (GLOBE NEWSWIRE) -- New APR Energy LLC (“APR Energy”), a global leader in fast-track power generation, has secured a contract to deliver 150 megawatts (MW) of power generation to support Mexico’s national utility ahead of …
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
GlobeNewswire
·
April 29, 2025
WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences
GlobeNewswire
·
April 29, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced that it will present new clinical …
Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress
GlobeNewswire
·
April 29, 2025
CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six …
Synchronoss Technologies Announces the Successful Completion of Debt Refinancing
GlobeNewswire
·
April 29, 2025
BRIDGEWATER, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, announced that it has entered into an agreement with TP Birch …
Immutep Quarterly Activities Report Q3 FY25
GlobeNewswire
·
April 29, 2025
Media Release First patient safely dosed in TACTI-004 Phase III lung cancer trial, marking a significant milestone Pivotal TACTI-004 trial design presented at the European Lung Cancer Congress (ELCC) 2025 Patient enrolment completed for the EFTISARC-NEO …
Reviva to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 29, 2025
CUPERTINO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewswire
·
April 29, 2025
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today reminds that CEO Dr. Ryan Saadi MD, MPH will participate in BioNJ’s Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be …
Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical …
LedgerAI Quantum Corporation Signs Strategic Engagement Letter with SMART to Strengthen AI Integration Across the U.S. Defense Industry
GlobeNewswire
·
April 29, 2025
New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- We are proud to announce a signed Strategic Engagement Letter with a scope of work with SMART (Strengthening the Mid-Atlantic Region for Tomorrow) - a nationally recognized organization driving innovation …
BestSATscore.com: SAT Prep Solution for the Digital SAT Practice Test
GlobeNewswire
·
April 29, 2025
Emeryville, California, April 29, 2025 (GLOBE NEWSWIRE) -- SAT Prep and SAT practice test are undergoing a transformation as the exam fully transitions into a digital format, and BestSATscore.com is leading the way with an all-in-one platform that covers …
Die Olon Group festigt ihre Führungsposition im Bereich Bioproduktion durch zwei strategische Ernennungen in Frankreich
GlobeNewswire
·
April 29, 2025
MAILAND, April 29, 2025 (GLOBE NEWSWIRE) -- Die Olon Group, ein weltweit führender CDMO-Anbieter im Pharmabereich, gibt die Ernennung von Jérôme Bédier zum CEO seiner französischen Unternehmen und von Andrea Conforto zum M…
Olon Group renforce son leadership dans la bioproduction avec deux nominations stratégiques en France
GlobeNewswire
·
April 29, 2025
MILAN, 29 avr. 2025 (GLOBE NEWSWIRE) -- Olon Group, acteur mondial de référence dans les services CDMO pharmaceutiques, annonce la nomination de Jérôme Bédier comme PDG de ses entités françaises, et d’Andrea Conforto comme vice-président M…
オロングループ (Olon Group) 、フランスにおける2件の戦略的な任命によりバイオ生産分野でのリーダーシップを強化
GlobeNewswire
·
April 29, 2025
ミラノ発, April 29, 2025 (GLOBE NEWSWIRE) -- 世界有数の製薬CDMOであるオロングループは、フランス法人のCEOにジェローム・ベディエ (Jérôme Bédier) を、バイオ医薬品向けCDMOサービスに特化した部門であるオロン・バイオテック (Olon Biotech) のM…